Maysa Vilbert

12PUBLICATIONS
40CO-AUTHORS
Molecular targetsMicrotechnologyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 13, 2026
Multi-Targeted TKIs in Patients with Advanced Ewing Sarcoma: A Systematic Review and Single-Arm Meta-Analysis.

Isabella Michelon, Caio Ernesto do Rêgo Castro, Ana Paula Querino Belluco

|Dec 19, 2024
It Takes a Village! Navigating the Challenges and Opportunities in Immune-Related Adverse Event Management.

Maysa Vilbert, Leyre Zubiri, Meghan J Mooradian

|Dec 17, 2024
Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor-Positive Advanced Breast Cancer.

Lis Victoria Ravani, Pedro Calomeni, Maysa Vilbert

|Nov 22, 2024
Safety and Efficacy of Osimertinib in Patients With Non-Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis.

Jonathan N Priantti, Yu Fujiwara, Francisco Cezar Aquino de Moraes

|Jul 27, 2024
EGFR-Tyrosine Kinase Inhibitor Retreatment in Non-Small-Cell Lung Cancer Patients Previously Exposed to EGFR-TKI: A Systematic Review and Meta-Analysis.

Isabella Michelon, Maysa Vilbert, Caio Ernesto do Rego Castro

|Jul 27, 2024
Neurocognitive Adverse Events Related to Lorlatinib in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Jonathan N Priantti, Maysa Vilbert, Francisco Cezar Aquino de Moraes

Pageof 2

Frequent Collaborators

6 joint publications

Ludimila Cavalcante

5 joint publications

Jonathan N Priantti

4 joint publications

Francisco Cezar Aquino de Moraes

3 joint publications

Isabella Michelon